v3.26.1
Condensed Consolidated Statements of Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Condensed Consolidated Statements of Loss        
Product revenue, net $ 559 $ 0 $ 797 $ 0
License and other revenue 0 0 0 0
Total revenues 559   797  
Operating Expenses        
Cost of product sales 32 0 46 0
Research and development, net of tax credits 3,509 3,669 6,760 8,647
Selling, general and administrative 22,648 8,862 43,284 24,407
Total operating expenses 26,189 12,531 50,090 33,054
Loss from operations (25,630) (12,531) (49,293) (33,054)
Interest income 1,741 516 3,473 1,213
Interest expense (4,725) (951) (8,860) (1,886)
Net loss and comprehensive loss $ (28,614) $ (12,966) $ (54,680) $ (33,727)
Weighted average number of shares and pre-funded warrants outstanding, basic (in shares) 138,691,580 66,380,118 134,512,026 66,333,024
Weighted average number of shares and pre-funded warrants outstanding, diluted (in shares) 138,691,580 66,380,118 134,512,026 66,333,024
Net loss per share, basic (in dollars per share) $ (0.21) $ (0.2) $ (0.41) $ (0.51)
Net loss per share, diluted (in dollars per share) $ (0.21) $ (0.2) $ (0.41) $ (0.51)